SECTOR
Jubilant Pharmova gets USFDA's approval for new Isolator based fill and finish line at Spokane Facility
Aug-24-2026

Jubilant Pharmova has received USFDA’s approval for the commercial batch manufacturing of the first product on the new Isolator based fill and finish line, Line 3 of Jubilant HollisterStier LLC (JHS)’s contract manufacturing facility located in Spokane, WA. U.S.A.

Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma, Singapore, a wholly owned subsidiary of the company.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

  RELATED NEWS >>